Walgreens Boots Alliance (NASDAQ:WBA) Price Target Raised to $13.00

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective boosted by Truist Financial from $10.00 to $13.00 in a research note issued to investors on Thursday,Benzinga reports. Truist Financial currently has a hold rating on the pharmacy operator’s stock.

A number of other equities research analysts have also commented on the company. Morgan Stanley decreased their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Royal Bank of Canada upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday. UBS Group raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Finally, Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $13.27.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $12.52 on Thursday. The firm has a market capitalization of $10.81 billion, a P/E ratio of -1.22, a P/E/G ratio of 1.55 and a beta of 0.64. The stock has a fifty day moving average price of $9.57 and a two-hundred day moving average price of $9.86. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $23.76. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the firm posted $0.66 EPS. As a group, analysts anticipate that Walgreens Boots Alliance will post 1.52 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a $0.25 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.99%. Walgreens Boots Alliance’s dividend payout ratio is -9.77%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Acadian Asset Management LLC raised its position in shares of Walgreens Boots Alliance by 1,444.1% during the second quarter. Acadian Asset Management LLC now owns 15,456 shares of the pharmacy operator’s stock worth $186,000 after purchasing an additional 14,455 shares during the period. DekaBank Deutsche Girozentrale raised its holdings in Walgreens Boots Alliance by 4.0% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 147,305 shares of the pharmacy operator’s stock worth $1,787,000 after buying an additional 5,636 shares during the period. Edgestream Partners L.P. bought a new position in Walgreens Boots Alliance in the second quarter valued at approximately $655,000. Amalgamated Bank boosted its holdings in shares of Walgreens Boots Alliance by 13.2% in the second quarter. Amalgamated Bank now owns 217,597 shares of the pharmacy operator’s stock valued at $2,632,000 after buying an additional 25,439 shares during the period. Finally, Vanguard Personalized Indexing Management LLC increased its position in shares of Walgreens Boots Alliance by 19.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 52,400 shares of the pharmacy operator’s stock worth $633,000 after acquiring an additional 8,538 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.